QIAGEN Teams with China's Lepu Medical to Provide Rapid Diagnosis of Heart Attacks Using Point of Need TestingSeptember 13, 2012 4:01 pm | by The Associated Press | News | Comments
QIAGEN's cutting-edge ESEQuant Lateral Flow System will run Lepu Medical's tests for key cardiac biomarkers to deliver lifesaving information in emergency rooms -- Cardiac testing adds further momentum for QIAGEN in fast-growing Chinese market -- Pioneering ESEQuant platform achieves first regulatory approval in human healthcare, expanding QIAGEN's global Point of Need business QIAGEN N.V.
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly SuperbugAugust 16, 2012 11:45 am | by PRNewswire via COMTEX | News | Comments
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced that the new BD MAX MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). Performed on the fully-automated BD MAX System, the assay is designed to rapidly and accurately identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA).
Tiny space age probes--those that can see inside single living cells--are increasingly being used to diagnose illness in hard-to-reach areas of the body. NewYork-Presbyterian Hospital/Weill Cornell Medical Center's Dr. Michel Kahaleh often threads a tiny microscope into the narrow bile ducts that connect the liver to the small intestine to hunt for cancer.
Lab on a chip (LOC) devices -- microchip-size systems that can prepare and analyze tiny fluid samples with volumes ranging from a few microliters (millionth of a liter) to sub-nanoliters (less than a billionth of a liter) -- are envisioned to one day revolutionize how laboratory tasks such as diagnosing diseases and investigating forensic evidence are performed.
The intricate properties of the fingertips have been mimicked and recreated using semiconductor devices in what researchers hope will lead to the development of advanced surgical gloves. The devices, shown to be capable of responding with high precision to the stresses and strains associated with touch and finger movement...
AspenBio Pharma, Inc., an in vitro diagnostic company, announced that it has submitted a pre-IDE (Investigational Device Exemption) information package to the U. S. Food and Drug Administration (FDA) for the use of the AppyScore™ test system to aid physicians...
US demand for in vitro (IVD) diagnostic products is forecast to increase 6.1 percent annually to $24.7 billion in 2016. An expanding volume of patient care activity, spurred by aging demographic patterns, a rising incidence of diseases and disorders, and the extension of health insurance coverage by the Affordable Care Act of 2010...
There is a new solution of materials managers dealing with excess inventory. MDLMedical.com is a members-only, on-line exchange that helps hospitals and surgical centers buy and sell unused, new medical devices and implants; purchase needed inventory at market-determined prices and recover some of the costs of their idle surgical inventory.
Fidelis Diagnostics Partners with Exalenz Bioscience to Add H. pylori Breath Testing Solutions to Its Portfolio of ServicesAugust 7, 2012 9:00 am | by The Associated Press | News | Comments
LOS ANGELES--(BUSINESS WIRE)--Aug 7, 2012--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, today announced it has entered into a strategic partnership with Exalenz Bioscience, Inc., a medical device company specializing in the...
Endomagnetics, the company known for developing magnetic technology for use in breast cancer staging, has been awarded government funding to extend its application to another form of cancer. The project will explore the clinical feasibility of applying magnetic sentinel lymph node (SLN) detection to melanoma...
Groundbreaking report in Mayo Clinic Proceedings examines the implications of the Accountable Care Organization component of the Patient Protection and Affordable Care Act
Gen-Probe's products include tests for sexually transmitted diseases. Hologic expects the deal to deepen its women's health focus and make it a major provider of STD diagnostics.
Medicare's war on fraud is going high-tech with the opening of a $3.6 million command center that features a giant screen and the latest computer and communications gear.
Bias may be completely unintentional, but everyone has it to one degree or another. It is the responsibility of ethical scientists to acknowledge those biases so that research data can be viewed more accurately and science is not slanted.
Medical devices save countless lives, but an interdisciplinary research team warns that federal regulators need to improve how they track security and privacy problems in medical devices.
A technique, known as photoacoustics, can find some forms of melanoma even if only a few cancerous cells exist, but a recent study by MU researchers found that the technique was limited in its ability to identify other types of cancer.
Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C.
The patents cover the technology in Arradiance’s GEM-R2 and GEM-R2D2 nanofilms that functionalize bare detector substrates of any size or insulating material to enable noiseless, low signal amplification.
Genetic test maker 23andMe is asking the FDA to approve its personalized DNA test in a move that, if successful, could boost acceptance of technology that is viewed skeptically by leading scientists who question its usefulness.
A tiny vibrating cantilever sensor could soon help doctors and field clinicians quickly detect harmful toxins, bacteria and even indicators of certain types of cancer from small samples of blood or urine.
Six more patients suspected to have Ebola have been admitted to the hospital days after investigators confirmed an outbreak of the highly infectious disease in a remote corner of western Uganda, a health official said on Monday.
Medical and industrial equipment maker Roper Industries is buying hospital software company Sunquest Information Systems for approximately $1.42 billion.
DSM, a global leader in biomedical materials, today announced that its VitroStealth® non-biofouling coating is used in Afinion®, Axis-Shield’s next generation point-of-care diagnostic system. Physicians can use Afinion® during the span of an office visit and obtain patient lipid levels within a matter of minutes.
Epilepsy Organizations Award Funding for New Devices to Treat, Detect, and Monitor Epilepsy ConditionsJune 25, 2012 6:45 am | News | Comments
The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of the two non-profit epilepsy organizations to advance clinical development...
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the launch of its Nellcor™ SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform.